This site is intended for US healthcare professionals

Product Information

VIVITROL®

(naltrexone for extended-release injectable suspension)

Publications

Alkermes Sponsored Phase 3 Clinical Trials

Apr 2005
Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial
JAMA
AUTHOR(S)

Garbutt JC, Kranzler HR, O'Malley SS, Gastfriend DR, Pettinati HM, Silverman BL, Loewy JW, Ehrich EW, et al.

Apr 2011
Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial
The Lancet
AUTHOR(S)

Krupitsky E, Nunes EV, Ling W, Illeperuma A, Gastfriend DR, Silverman BL

Sep 2013
Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness
Addiction
AUTHOR(S)

Krupitsky E, Nunes EV, Ling W, Gastfriend DR, Memisoglu A, Silverman BL